Click for best price
VMAT2 Inhibitors Market Size, Share 2024
The global VMAT2 Inhibitors market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Tetrabenazine Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of VMAT2 Inhibitors include Neurocrine Biosciences, Inc, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Hikma Pharmaceuticals plc, Hetero, Bausch Health Companies Inc, Dr. Reddy's Laboratories Ltd, Piramal Pharma Solution and Lupin, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Vesicular monoamine transporter-2 is the transmembrane protein which is primarily responsible for the transport of monoamines neurotransmitters such as histamines, serotonin, dopamine, and norepinephrine into the synaptic vesicles. VMAT2 transporter carries the cytoplasmic dopamine into the vesicles. VMAT2 inhibitors reduce the dopamine at the presynaptic striatal nerve terminals and decrease unwanted body movements for these conditions. VMAT2 inhibitors are widely used to treat uncontrollable involuntary, repetitive body movements caused by tardive dyskinesia and Huntington?s disease.
This report aims to provide a comprehensive presentation of the global market for VMAT2 Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding VMAT2 Inhibitors. This report contains market size and forecasts of VMAT2 Inhibitors in global, including the following market information:
Global VMAT2 Inhibitors Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global VMAT2 Inhibitors Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five VMAT2 Inhibitors companies in 2023 (%)
We surveyed the VMAT2 Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global VMAT2 Inhibitors Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global VMAT2 Inhibitors Market Segment Percentages, by Type, 2023 (%)
Tetrabenazine
Valbenazine
Other
Global VMAT2 Inhibitors Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global VMAT2 Inhibitors Market Segment Percentages, by Application, 2023 (%)
Huntington?s Disease
Tardive Dyskinesia
Other
Global VMAT2 Inhibitors Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global VMAT2 Inhibitors Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies VMAT2 Inhibitors revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies VMAT2 Inhibitors revenues share in global market, 2023 (%)
Key companies VMAT2 Inhibitors sales in global market, 2019-2024 (Estimated), (K Units)
Key companies VMAT2 Inhibitors sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Neurocrine Biosciences, Inc
Teva Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd
Hikma Pharmaceuticals plc
Hetero
Bausch Health Companies Inc
Dr. Reddy's Laboratories Ltd
Piramal Pharma Solution
Lupin
Luye Pharma Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of VMAT2 Inhibitors, market overview.
Chapter 2: Global VMAT2 Inhibitors market size in revenue and volume.
Chapter 3: Detailed analysis of VMAT2 Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of VMAT2 Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global VMAT2 Inhibitors capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
VMAT2 Inhibitors Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
70 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 VMAT2 Inhibitors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global VMAT2 Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global VMAT2 Inhibitors Overall Market Size
2.1 Global VMAT2 Inhibitors Market Size: 2023 VS 2030
2.2 Global VMAT2 Inhibitors Revenue, Prospects & Forecasts: 2019-2030
2.3 Global VMAT2 Inhibitors Sales: 2019-2030
3 Company Landscape
3.1 Top VMAT2 Inhibitors Players in Global Market
3.2 Top Global VMAT2 Inhibitors Companies Ranked by Revenue
3.3 Global VMAT2 Inhibitors Revenue by Companies
3.4 Global VMAT2 Inhibitors Sales by Companies
3.5 Global VMAT2 Inhibitors Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 VMAT2 Inhibitors Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers VMAT2 Inhibitors Product Type
3.8 Tier 1, Tier 2 and Tier 3 VMAT2 Inhibitors Players in Global Market
3.8.1 List of Global Tier 1 VMAT2 Inhibitors Companies
3.8.2 List of Global Tier 2 and Tier 3 VMAT2 Inhibitors Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global VMAT2 Inhibitors Market Size Markets, 2023 & 2030
4.1.2 Tetrabenazine
4.1.3 Valbenazine
4.1.4 Other
4.2 By Type - Global VMAT2 Inhibitors Revenue & Forecasts
4.2.1 By Type - Global VMAT2 Inhibitors Revenue, 2019-2024
4.2.2 By Type - Global VMAT2 Inhibitors Revenue, 2025-2030
4.2.3 By Type - Global VMAT2 Inhibitors Revenue Market Share, 2019-2030
4.3 By Type - Global VMAT2 Inhibitors Sales & Forecasts
4.3.1 By Type - Global VMAT2 Inhibitors Sales, 2019-2024
4.3.2 By Type - Global VMAT2 Inhibitors Sales, 2025-2030
4.3.3 By Type - Global VMAT2 Inhibitors Sales Market Share, 2019-2030
4.4 By Type - Global VMAT2 Inhibitors Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global VMAT2 Inhibitors Market Size, 2023 & 2030
5.1.2 Huntington?s Disease
5.1.3 Tardive Dyskinesia
5.1.4 Other
5.2 By Application - Global VMAT2 Inhibitors Revenue & Forecasts
5.2.1 By Application - Global VMAT2 Inhibitors Revenue, 2019-2024
5.2.2 By Application - Global VMAT2 Inhibitors Revenue, 2025-2030
5.2.3 By Application - Global VMAT2 Inhibitors Revenue Market Share, 2019-2030
5.3 By Application - Global VMAT2 Inhibitors Sales & Forecasts
5.3.1 By Application - Global VMAT2 Inhibitors Sales, 2019-2024
5.3.2 By Application - Global VMAT2 Inhibitors Sales, 2025-2030
5.3.3 By Application - Global VMAT2 Inhibitors Sales Market Share, 2019-2030
5.4 By Application - Global VMAT2 Inhibitors Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global VMAT2 Inhibitors Market Size, 2023 & 2030
6.2 By Region - Global VMAT2 Inhibitors Revenue & Forecasts
6.2.1 By Region - Global VMAT2 Inhibitors Revenue, 2019-2024
6.2.2 By Region - Global VMAT2 Inhibitors Revenue, 2025-2030
6.2.3 By Region - Global VMAT2 Inhibitors Revenue Market Share, 2019-2030
6.3 By Region - Global VMAT2 Inhibitors Sales & Forecasts
6.3.1 By Region - Global VMAT2 Inhibitors Sales, 2019-2024
6.3.2 By Region - Global VMAT2 Inhibitors Sales, 2025-2030
6.3.3 By Region - Global VMAT2 Inhibitors Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America VMAT2 Inhibitors Revenue, 2019-2030
6.4.2 By Country - North America VMAT2 Inhibitors Sales, 2019-2030
6.4.3 US VMAT2 Inhibitors Market Size, 2019-2030
6.4.4 Canada VMAT2 Inhibitors Market Size, 2019-2030
6.4.5 Mexico VMAT2 Inhibitors Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe VMAT2 Inhibitors Revenue, 2019-2030
6.5.2 By Country - Europe VMAT2 Inhibitors Sales, 2019-2030
6.5.3 Germany VMAT2 Inhibitors Market Size, 2019-2030
6.5.4 France VMAT2 Inhibitors Market Size, 2019-2030
6.5.5 U.K. VMAT2 Inhibitors Market Size, 2019-2030
6.5.6 Italy VMAT2 Inhibitors Market Size, 2019-2030
6.5.7 Russia VMAT2 Inhibitors Market Size, 2019-2030
6.5.8 Nordic Countries VMAT2 Inhibitors Market Size, 2019-2030
6.5.9 Benelux VMAT2 Inhibitors Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia VMAT2 Inhibitors Revenue, 2019-2030
6.6.2 By Region - Asia VMAT2 Inhibitors Sales, 2019-2030
6.6.3 China VMAT2 Inhibitors Market Size, 2019-2030
6.6.4 Japan VMAT2 Inhibitors Market Size, 2019-2030
6.6.5 South Korea VMAT2 Inhibitors Market Size, 2019-2030
6.6.6 Southeast Asia VMAT2 Inhibitors Market Size, 2019-2030
6.6.7 India VMAT2 Inhibitors Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America VMAT2 Inhibitors Revenue, 2019-2030
6.7.2 By Country - South America VMAT2 Inhibitors Sales, 2019-2030
6.7.3 Brazil VMAT2 Inhibitors Market Size, 2019-2030
6.7.4 Argentina VMAT2 Inhibitors Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa VMAT2 Inhibitors Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa VMAT2 Inhibitors Sales, 2019-2030
6.8.3 Turkey VMAT2 Inhibitors Market Size, 2019-2030
6.8.4 Israel VMAT2 Inhibitors Market Size, 2019-2030
6.8.5 Saudi Arabia VMAT2 Inhibitors Market Size, 2019-2030
6.8.6 UAE VMAT2 Inhibitors Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Neurocrine Biosciences, Inc
7.1.1 Neurocrine Biosciences, Inc Company Summary
7.1.2 Neurocrine Biosciences, Inc Business Overview
7.1.3 Neurocrine Biosciences, Inc VMAT2 Inhibitors Major Product Offerings
7.1.4 Neurocrine Biosciences, Inc VMAT2 Inhibitors Sales and Revenue in Global (2019-2024)
7.1.5 Neurocrine Biosciences, Inc Key News & Latest Developments
7.2 Teva Pharmaceutical Industries Ltd
7.2.1 Teva Pharmaceutical Industries Ltd Company Summary
7.2.2 Teva Pharmaceutical Industries Ltd Business Overview
7.2.3 Teva Pharmaceutical Industries Ltd VMAT2 Inhibitors Major Product Offerings
7.2.4 Teva Pharmaceutical Industries Ltd VMAT2 Inhibitors Sales and Revenue in Global (2019-2024)
7.2.5 Teva Pharmaceutical Industries Ltd Key News & Latest Developments
7.3 Sun Pharmaceutical Industries Ltd
7.3.1 Sun Pharmaceutical Industries Ltd Company Summary
7.3.2 Sun Pharmaceutical Industries Ltd Business Overview
7.3.3 Sun Pharmaceutical Industries Ltd VMAT2 Inhibitors Major Product Offerings
7.3.4 Sun Pharmaceutical Industries Ltd VMAT2 Inhibitors Sales and Revenue in Global (2019-2024)
7.3.5 Sun Pharmaceutical Industries Ltd Key News & Latest Developments
7.4 Hikma Pharmaceuticals plc
7.4.1 Hikma Pharmaceuticals plc Company Summary
7.4.2 Hikma Pharmaceuticals plc Business Overview
7.4.3 Hikma Pharmaceuticals plc VMAT2 Inhibitors Major Product Offerings
7.4.4 Hikma Pharmaceuticals plc VMAT2 Inhibitors Sales and Revenue in Global (2019-2024)
7.4.5 Hikma Pharmaceuticals plc Key News & Latest Developments
7.5 Hetero
7.5.1 Hetero Company Summary
7.5.2 Hetero Business Overview
7.5.3 Hetero VMAT2 Inhibitors Major Product Offerings
7.5.4 Hetero VMAT2 Inhibitors Sales and Revenue in Global (2019-2024)
7.5.5 Hetero Key News & Latest Developments
7.6 Bausch Health Companies Inc
7.6.1 Bausch Health Companies Inc Company Summary
7.6.2 Bausch Health Companies Inc Business Overview
7.6.3 Bausch Health Companies Inc VMAT2 Inhibitors Major Product Offerings
7.6.4 Bausch Health Companies Inc VMAT2 Inhibitors Sales and Revenue in Global (2019-2024)
7.6.5 Bausch Health Companies Inc Key News & Latest Developments
7.7 Dr. Reddy's Laboratories Ltd
7.7.1 Dr. Reddy's Laboratories Ltd Company Summary
7.7.2 Dr. Reddy's Laboratories Ltd Business Overview
7.7.3 Dr. Reddy's Laboratories Ltd VMAT2 Inhibitors Major Product Offerings
7.7.4 Dr. Reddy's Laboratories Ltd VMAT2 Inhibitors Sales and Revenue in Global (2019-2024)
7.7.5 Dr. Reddy's Laboratories Ltd Key News & Latest Developments
7.8 Piramal Pharma Solution
7.8.1 Piramal Pharma Solution Company Summary
7.8.2 Piramal Pharma Solution Business Overview
7.8.3 Piramal Pharma Solution VMAT2 Inhibitors Major Product Offerings
7.8.4 Piramal Pharma Solution VMAT2 Inhibitors Sales and Revenue in Global (2019-2024)
7.8.5 Piramal Pharma Solution Key News & Latest Developments
7.9 Lupin
7.9.1 Lupin Company Summary
7.9.2 Lupin Business Overview
7.9.3 Lupin VMAT2 Inhibitors Major Product Offerings
7.9.4 Lupin VMAT2 Inhibitors Sales and Revenue in Global (2019-2024)
7.9.5 Lupin Key News & Latest Developments
7.10 Luye Pharma Group
7.10.1 Luye Pharma Group Company Summary
7.10.2 Luye Pharma Group Business Overview
7.10.3 Luye Pharma Group VMAT2 Inhibitors Major Product Offerings
7.10.4 Luye Pharma Group VMAT2 Inhibitors Sales and Revenue in Global (2019-2024)
7.10.5 Luye Pharma Group Key News & Latest Developments
8 Global VMAT2 Inhibitors Production Capacity, Analysis
8.1 Global VMAT2 Inhibitors Production Capacity, 2019-2030
8.2 VMAT2 Inhibitors Production Capacity of Key Manufacturers in Global Market
8.3 Global VMAT2 Inhibitors Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 VMAT2 Inhibitors Supply Chain Analysis
10.1 VMAT2 Inhibitors Industry Value Chain
10.2 VMAT2 Inhibitors Upstream Market
10.3 VMAT2 Inhibitors Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 VMAT2 Inhibitors Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of VMAT2 Inhibitors in Global Market
Table 2. Top VMAT2 Inhibitors Players in Global Market, Ranking by Revenue (2023)
Table 3. Global VMAT2 Inhibitors Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global VMAT2 Inhibitors Revenue Share by Companies, 2019-2024
Table 5. Global VMAT2 Inhibitors Sales by Companies, (K Units), 2019-2024
Table 6. Global VMAT2 Inhibitors Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers VMAT2 Inhibitors Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers VMAT2 Inhibitors Product Type
Table 9. List of Global Tier 1 VMAT2 Inhibitors Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 VMAT2 Inhibitors Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global VMAT2 Inhibitors Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global VMAT2 Inhibitors Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global VMAT2 Inhibitors Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global VMAT2 Inhibitors Sales (K Units), 2019-2024
Table 15. By Type - Global VMAT2 Inhibitors Sales (K Units), 2025-2030
Table 16. By Application ? Global VMAT2 Inhibitors Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global VMAT2 Inhibitors Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global VMAT2 Inhibitors Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global VMAT2 Inhibitors Sales (K Units), 2019-2024
Table 20. By Application - Global VMAT2 Inhibitors Sales (K Units), 2025-2030
Table 21. By Region ? Global VMAT2 Inhibitors Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global VMAT2 Inhibitors Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global VMAT2 Inhibitors Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global VMAT2 Inhibitors Sales (K Units), 2019-2024
Table 25. By Region - Global VMAT2 Inhibitors Sales (K Units), 2025-2030
Table 26. By Country - North America VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America VMAT2 Inhibitors Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America VMAT2 Inhibitors Sales, (K Units), 2019-2024
Table 29. By Country - North America VMAT2 Inhibitors Sales, (K Units), 2025-2030
Table 30. By Country - Europe VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe VMAT2 Inhibitors Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe VMAT2 Inhibitors Sales, (K Units), 2019-2024
Table 33. By Country - Europe VMAT2 Inhibitors Sales, (K Units), 2025-2030
Table 34. By Region - Asia VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia VMAT2 Inhibitors Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia VMAT2 Inhibitors Sales, (K Units), 2019-2024
Table 37. By Region - Asia VMAT2 Inhibitors Sales, (K Units), 2025-2030
Table 38. By Country - South America VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America VMAT2 Inhibitors Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America VMAT2 Inhibitors Sales, (K Units), 2019-2024
Table 41. By Country - South America VMAT2 Inhibitors Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa VMAT2 Inhibitors Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa VMAT2 Inhibitors Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa VMAT2 Inhibitors Sales, (K Units), 2025-2030
Table 46. Neurocrine Biosciences, Inc Company Summary
Table 47. Neurocrine Biosciences, Inc VMAT2 Inhibitors Product Offerings
Table 48. Neurocrine Biosciences, Inc VMAT2 Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Neurocrine Biosciences, Inc Key News & Latest Developments
Table 50. Teva Pharmaceutical Industries Ltd Company Summary
Table 51. Teva Pharmaceutical Industries Ltd VMAT2 Inhibitors Product Offerings
Table 52. Teva Pharmaceutical Industries Ltd VMAT2 Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Teva Pharmaceutical Industries Ltd Key News & Latest Developments
Table 54. Sun Pharmaceutical Industries Ltd Company Summary
Table 55. Sun Pharmaceutical Industries Ltd VMAT2 Inhibitors Product Offerings
Table 56. Sun Pharmaceutical Industries Ltd VMAT2 Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Sun Pharmaceutical Industries Ltd Key News & Latest Developments
Table 58. Hikma Pharmaceuticals plc Company Summary
Table 59. Hikma Pharmaceuticals plc VMAT2 Inhibitors Product Offerings
Table 60. Hikma Pharmaceuticals plc VMAT2 Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Hikma Pharmaceuticals plc Key News & Latest Developments
Table 62. Hetero Company Summary
Table 63. Hetero VMAT2 Inhibitors Product Offerings
Table 64. Hetero VMAT2 Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Hetero Key News & Latest Developments
Table 66. Bausch Health Companies Inc Company Summary
Table 67. Bausch Health Companies Inc VMAT2 Inhibitors Product Offerings
Table 68. Bausch Health Companies Inc VMAT2 Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Bausch Health Companies Inc Key News & Latest Developments
Table 70. Dr. Reddy's Laboratories Ltd Company Summary
Table 71. Dr. Reddy's Laboratories Ltd VMAT2 Inhibitors Product Offerings
Table 72. Dr. Reddy's Laboratories Ltd VMAT2 Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Dr. Reddy's Laboratories Ltd Key News & Latest Developments
Table 74. Piramal Pharma Solution Company Summary
Table 75. Piramal Pharma Solution VMAT2 Inhibitors Product Offerings
Table 76. Piramal Pharma Solution VMAT2 Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Piramal Pharma Solution Key News & Latest Developments
Table 78. Lupin Company Summary
Table 79. Lupin VMAT2 Inhibitors Product Offerings
Table 80. Lupin VMAT2 Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Lupin Key News & Latest Developments
Table 82. Luye Pharma Group Company Summary
Table 83. Luye Pharma Group VMAT2 Inhibitors Product Offerings
Table 84. Luye Pharma Group VMAT2 Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Luye Pharma Group Key News & Latest Developments
Table 86. VMAT2 Inhibitors Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 87. Global VMAT2 Inhibitors Capacity Market Share of Key Manufacturers, 2022-2024
Table 88. Global VMAT2 Inhibitors Production by Region, 2019-2024 (K Units)
Table 89. Global VMAT2 Inhibitors Production by Region, 2025-2030 (K Units)
Table 90. VMAT2 Inhibitors Market Opportunities & Trends in Global Market
Table 91. VMAT2 Inhibitors Market Drivers in Global Market
Table 92. VMAT2 Inhibitors Market Restraints in Global Market
Table 93. VMAT2 Inhibitors Raw Materials
Table 94. VMAT2 Inhibitors Raw Materials Suppliers in Global Market
Table 95. Typical VMAT2 Inhibitors Downstream
Table 96. VMAT2 Inhibitors Downstream Clients in Global Market
Table 97. VMAT2 Inhibitors Distributors and Sales Agents in Global Market
List of Figures
Figure 1. VMAT2 Inhibitors Segment by Type in 2023
Figure 2. VMAT2 Inhibitors Segment by Application in 2023
Figure 3. Global VMAT2 Inhibitors Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global VMAT2 Inhibitors Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global VMAT2 Inhibitors Revenue, 2019-2030 (US$, Mn)
Figure 7. VMAT2 Inhibitors Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by VMAT2 Inhibitors Revenue in 2023
Figure 9. By Type - Global VMAT2 Inhibitors Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global VMAT2 Inhibitors Revenue Market Share, 2019-2030
Figure 11. By Type - Global VMAT2 Inhibitors Sales Market Share, 2019-2030
Figure 12. By Type - Global VMAT2 Inhibitors Price (US$/Unit), 2019-2030
Figure 13. By Application - Global VMAT2 Inhibitors Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global VMAT2 Inhibitors Revenue Market Share, 2019-2030
Figure 15. By Application - Global VMAT2 Inhibitors Sales Market Share, 2019-2030
Figure 16. By Application - Global VMAT2 Inhibitors Price (US$/Unit), 2019-2030
Figure 17. By Region - Global VMAT2 Inhibitors Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global VMAT2 Inhibitors Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global VMAT2 Inhibitors Revenue Market Share, 2019-2030
Figure 20. By Region - Global VMAT2 Inhibitors Sales Market Share, 2019-2030
Figure 21. By Country - North America VMAT2 Inhibitors Revenue Market Share, 2019-2030
Figure 22. By Country - North America VMAT2 Inhibitors Sales Market Share, 2019-2030
Figure 23. US VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 24. Canada VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe VMAT2 Inhibitors Revenue Market Share, 2019-2030
Figure 27. By Country - Europe VMAT2 Inhibitors Sales Market Share, 2019-2030
Figure 28. Germany VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 29. France VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 31. Italy VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 32. Russia VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia VMAT2 Inhibitors Revenue Market Share, 2019-2030
Figure 36. By Region - Asia VMAT2 Inhibitors Sales Market Share, 2019-2030
Figure 37. China VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 38. Japan VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 41. India VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America VMAT2 Inhibitors Revenue Market Share, 2019-2030
Figure 43. By Country - South America VMAT2 Inhibitors Sales Market Share, 2019-2030
Figure 44. Brazil VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa VMAT2 Inhibitors Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa VMAT2 Inhibitors Sales Market Share, 2019-2030
Figure 48. Turkey VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 49. Israel VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 51. UAE VMAT2 Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 52. Global VMAT2 Inhibitors Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production VMAT2 Inhibitors by Region, 2023 VS 2030
Figure 54. VMAT2 Inhibitors Industry Value Chain
Figure 55. Marketing Channels
